Aurobindo Pharma shares jump nearly 2% after Telangana plant vai
NewsBytes | May 6, 2026 1:39 PM CST
TheraNym Biologics partners with Merck
The VAI tag signals objectionable conditions were found during the inspection, which reassured investors and pushed shares to ₹1,450.90 by this morning.
Meanwhile, Aurobindo's subsidiary TheraNym Biologics is stepping up too: they're teaming up with Merck to build a new $150 million to $175 million drug manufacturing facility.
Over the past month, Aurobindo's stock has climbed 8%, and it's up more than 27% in six months.
READ NEXT
-
Exciting Railway Job Openings for 10th Pass Candidates in 2026-27
-
SECL Recruitment 2026: Apply for 1,055 Government Job Vacancies
-
Bihar Government Empowers MBBS Doctors to Conduct Ultrasounds After Training
-
HSSC CET Group C 2025 Biometric Verification Schedule Released
-
UP Home Guard Answer Key 2026 Released by UPPRPB
